1. Home
  2. TLSI vs NTIC Comparison

TLSI vs NTIC Comparison

Compare TLSI & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSI
  • NTIC
  • Stock Information
  • Founded
  • TLSI 2010
  • NTIC 1970
  • Country
  • TLSI United States
  • NTIC United States
  • Employees
  • TLSI N/A
  • NTIC N/A
  • Industry
  • TLSI Medical Specialities
  • NTIC Industrial Specialties
  • Sector
  • TLSI Health Care
  • NTIC Industrials
  • Exchange
  • TLSI Nasdaq
  • NTIC Nasdaq
  • Market Cap
  • TLSI 124.9M
  • NTIC 116.9M
  • IPO Year
  • TLSI N/A
  • NTIC N/A
  • Fundamental
  • Price
  • TLSI $3.94
  • NTIC $14.19
  • Analyst Decision
  • TLSI Strong Buy
  • NTIC Buy
  • Analyst Count
  • TLSI 6
  • NTIC 1
  • Target Price
  • TLSI $11.75
  • NTIC $20.00
  • AVG Volume (30 Days)
  • TLSI 52.7K
  • NTIC 23.7K
  • Earning Date
  • TLSI 11-14-2024
  • NTIC 01-09-2025
  • Dividend Yield
  • TLSI N/A
  • NTIC 1.94%
  • EPS Growth
  • TLSI N/A
  • NTIC 83.33
  • EPS
  • TLSI N/A
  • NTIC 0.55
  • Revenue
  • TLSI $26,891,000.00
  • NTIC $85,059,517.00
  • Revenue This Year
  • TLSI $60.97
  • NTIC $11.04
  • Revenue Next Year
  • TLSI $53.69
  • NTIC $8.10
  • P/E Ratio
  • TLSI N/A
  • NTIC $26.22
  • Revenue Growth
  • TLSI 67.90
  • NTIC 6.45
  • 52 Week Low
  • TLSI $3.50
  • NTIC $11.06
  • 52 Week High
  • TLSI $10.42
  • NTIC $19.63
  • Technical
  • Relative Strength Index (RSI)
  • TLSI 46.18
  • NTIC 56.41
  • Support Level
  • TLSI $3.76
  • NTIC $14.01
  • Resistance Level
  • TLSI $4.17
  • NTIC $14.49
  • Average True Range (ATR)
  • TLSI 0.35
  • NTIC 0.46
  • MACD
  • TLSI -0.04
  • NTIC 0.03
  • Stochastic Oscillator
  • TLSI 33.66
  • NTIC 81.13

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.

Share on Social Networks: